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Light chain multiple myeloma occurs in 20% of multiple myeloma cases. Extramedullary dissemination of
multiple myeloma is rare and involvement of pleura by it is even more rare. A 40 years old female patient
presented with complains of recurrent vomiting for last 2 months and cough with expectoration for last
1 week. Chest X-Ray (PA view) showed a rounded homogenous opacity in mid zone of left lung ﬁeld.
CECT (thorax) showed pleura based soft tissue density mass lesions overlying apicoposterior segment of
left upper lobe and lingular lobe with lytic destruction of underlying 2nd rib. Ultrasound scan of
abdomen was normal. CT guided FNAC from soft tissue mass lesion of left side revealed atypical plasma
cells, some of them were binucleate and few appear pleomorphic. Bone marrow aspiration showed 20%
atypical plasma cells. Serum protein electrophoresis revealed a thin discrete band in gamma globulin
region, while serum immunoﬁxation electrophoresis showed presence of lambda light chain band only,
with absence of kappa band, IgG band, IgM band and IgA band. Patient was diagnosed as a case of lambda
light chain multiple myeloma with extramedullary dissemination to pleura presenting as pleural mass.
 2010 Elsevier Ltd. All rights reserved.1. Introduction
Multiple myeloma is characterized by malignant proliferation of
plasma cells with an overproduction of monoclonal proteins
usually producing IgG and IgA, but in 20% of cases only light chains
are produced, which is termed as light chain myeloma.1 Multiple
myeloma is usually restricted to the bone and bone marrow and
extramedullary involvement in multiple myeloma is rare, usually
involving the nasopharynx, upper respiratory tract, or gastroin-
testinal tract.2e5 The pleural involvement is even more rare in
multiple myeloma.6,7
Here, we are presenting a case of lambda light chain multiple
myeloma, inwhich the malignant plasma cells had disseminated to
the pleura and presented as pleural mass.2. Case report
A 40 years old female patient presented with complains of
recurrent vomiting for last 2 months and cough with expectoration
for last 1 week. There was no history of fever, chest pain, dyspnoea,
haemoptysis, abdominal pain or abdominal distension. On physical
examination, BP-110/80,PR-78/min, RR-20/min and patient was
a febrile. There was no lymadenopathy. Examination of respiratoryom (M. Shameem).
rved.system, cardiovascular system, central nervous system and GI
system revealed no abnormal ﬁnding.
Laboratory investigations revealed, Hb 8.0 g/dl, TLC 10,200 per
cumm, platelets count 1.2 lakh per cumm and ESR 60 mm in Ist h
(Westergren). The blood sugar-90 mg/dl, blood urea-52.4 mg/dl
and serum creatinine-1.46 mg/dl at presentation. The serum uric
acid, liver function test, serum calcium, and phosphorus were
within normal limit.
Chest X-Ray-PA view (Fig. 1) showed a rounded homogenous
opacity in mid zone of left lung ﬁeld. CECT-thorax showed pleura
based soft tissue density mass lesions overlying apicoposterior
segment of left upper lobe and lingular lobe with lytic destruction
of underlying 2nd rib (Fig. 2). Ultrasound scan of abdomen was
normal.
CT guided FNAC from soft tissue mass lesion of left side revealed
atypical plasma cells, some of themwere binucleate and fewappear
pleomorphic. Bone marrow aspiration showed 20% atypical plasma
cells.
X-ray of skull and dorsolumbar spine was done which revealed
absence of any lytic lesion.
Serum protein electrophoresis revealed a thin discrete band in
gamma globulin region. The total protein was 4.4 g/dl [6.4e8.2],
albumin-2.74 g/dl [3.20e4.60], alpha1 globulin-0.16 g/dl [0.15e0.33],
alpha2 globulin-0.49 g/dl [0.72e1.06], beta globulin-0.43 g/dl
[0.74e1.06] and gamma globulin-0.58 g/dl [0.91e1.71]. Serum
immunoﬁxation electrophoresis revealed presence of lambda light
chain band only .The kappa band, IgG band, IgM band and IgA band
Fig. 1. CXR PA view showing rounded homogenous opacity in mid zone of left lung
ﬁeld.
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was negative.
Patient was diagnosed as a case of lambda light chain multiple
myeloma with extramedullary dissemination to pleura presenting
as pleural mass. Patient was referred to department of radiotherapy
for further management, where lenalidomideedexamethasone
chemotherapy regimen was started.3. Discussion
Multiple myeloma is a neoplastic disorder of plasma cells.
Plasma cells are a type of B cell, responsible for the production of
immunoglobulins. It is the second most common hematological
malignancy after non Hodgkins lymphoma.8 It occurs primarily in
the 65e75 years of age group. The classic triad of myeloma is
marrow plasmacytosis (>10%), lytic bone lesions and a serum or
urine monoclonal (M) component. The presenting features are
bone pains, renal dysfunction, infections (pneumonia, pyelone-
phritis), and neurological manifestations. Hypercalcaemia, hyper-
uricemia and anaemia are common lab ﬁndings.Fig. 2. CECT(thorax)showing pleura based soft tissue density mass lesion with lytic
destruction of 2nd rib on left side.In multiple myeloma, there is increased concentration of
monoclonal protein, which is an abnormal immunoglobulin
produced by malignant plasma cells, along with normal or reduced
concentration of other normal immunoglobulins. Generally one
heavy type of immunoglobulin is increased, most commonly IgG
followed by IgA. Monoclonal protein is seen as a spike in gamma
region of serum electrophoretic pattern. However, in 20% of
multiple myeloma cases, there is production of only light chain as
monoclonal protein and this condition is known as light chain
myeloma.1 The heat test for detecting Bence Jones protein is falsely
negative in 50% of patients with light chain myeloma.1 The light
chain isotype may have an impact on survival. Patients secreting
lambda light chains have a signiﬁcantly shorter overall survival
than those secreting kappa light chains. In IgD myeloma, the light
chain is lambda and the patients often present with a protein
electrophoretic pattern showing a normal or a hypogammaglo-
bulinemic pattern. All these features make IgD myeloma to be
similar to lambda light chain myeloma.9
Multiplemyeloma is usually restricted tobone andbonemarrow.
Extramedullary involvement in multiple myeloma is rare and if
presentusually involves thenasopharynx,upper respiratory tract, or
gastrointestinal tract.2e5 Extramedullary involvement may be
primary or secondary to dissemination of multiple myeloma.5Sites
such as lymph node, thyroid, intestinal tract, ovary, kidney, and skin
were reported to be involved by myeloma cells by Hellwig.10,11
Intrathoracic involvement in multiple myeloma is very rare.12,13
Myeloma cells may involve lung parenchyma in form of lung
mass14,15 or pulmonary nodules.16 Pleural involvement in multiple
myeloma may manifest as pleural effusion,17 pleural mass or
nodule.16 Herskovic found intrathoracic involvement in 21 patients
out of 303patients ofmultiplemyeloma reviewed atMayo clinic and
out of these 21 cases some presented as intrathoracic mass.18 A case
of pleuralmass associatedwithmyelomawas reportedbyGalgano,19
as well as by Arnold et al.5 Here, we are presenting a case of lambda
light chain multiple myeloma that presented to us as pleural mass
due to extramedullary dissemination of myeloma cells to pleura, in
order to highlight atypical presentation of multiple myeloma.
Treatment ofmultiplemyelomadepends on thepatient's age and
comorbidities. Under 65 years of age, thalidomideedexamethasone,
lenalidomideedexamethasone or bortezomib based high dose
chemotherapy regimen is given, alongwithhematopoietic stem-cell
transplantation.20 Patients over age 65 and patients with signiﬁcant
concurrent illness, who cannot tolerate stem-cell transplantation,
are treatedwithmelphalan and prednisone chemotherapy regimen.
However, new chemotherapy regimens such as bortezomib,
melphalan and prednisolone,21 lenalidomide plus low dose dexa-
methasone or melphalan, prednisolone and lenalidomide has
shown improved outcome in this age group.
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